Atrial natriuretic peptide and plasma renin levels in assessment of mineralocorticoid replacement in Addison's disease

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 4, 1996, Pages 1411-1415

  Cohen, N ^a   Gilbert, R ^a   Wirth, A ^a   Casley, D ^a   Jerums, G ^a  

^a AUSTIN HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CORTISONE ACETATE; FLUDROCORTISONE; MINERALOCORTICOID; PREDNISOLONE; RENIN; SODIUM;

ABDOMINAL PAIN; ADDISON DISEASE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOSE RESPONSE; EDEMA; FEMALE; FLUID BALANCE; HORMONAL THERAPY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MUSCLE WEAKNESS; ORAL DRUG ADMINISTRATION; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; SODIUM BALANCE; THIRST; VERTIGO;

ADDISON DISEASE; ADULT; AGED; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; CORTISONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG MONITORING; FEMALE; FLUDROCORTISONE; HUMANS; MALE; MIDDLE AGED; MINERALOCORTICOIDS; POTASSIUM; PREDNISOLONE; RENIN;

EID: 0029887954     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.4.1411     Document Type: Article

References (25)

1. Oelkers W, Diedrich S, Bahr V. 1992 Diagnosis and therapy surveillance in Addison's disease: rapid adrenocorticotropin (ACTH) test and measurement of plasma ACTH, renin activity, and aldosterone. J Clin Endocrinol Metab. 75:259-264.
2. Thompson DG, Stuart Mason A, Goodwin FJ. 1979 Mineralocorticoid replacement in Addison's disease. Clin Endocrinol (Oxf). 10:499-506.
3. Smith S, Markandu N, Banks R, et al. 1984 Evidence that patients with Addison's disease are under-treated with fludrocortisone. Lancet. 1:11-14.
4. Jadoul M, Ferrant A, De Plaen J, Crabbe J. 1991 Mineralocorticoids in the management of primary adrenocortical insufficiency. J Endocrinol Invest. 14: 87-91.
5. Conte G, Romano G, Sepe V, et al. 1992 Role of inhibition of atrial natriuretic factor release in the down-regulation of salt excretion. Kidney Int. 42:673-680.
6. De Zeeuw D, Janssen WM, De Jong PE. 1992 Atrial natriuretic factor: its (patho)physiological significance in humans. Kidney Int. 41:1115-1133.
7. Awazu M, Ichikawa I. 1993 Biological significance of atrial natriuretic peptide in the kidney. Nephron. 63:1-14.
8. Opocher G, Rocca S, Carpene G, Vettoretti A, Cimolato M, Mantero F. 1992 Usefulness of atrial natriuretic peptide assay in primary aldosteronism. Am J Hypertens. 5:811-816.
9. Sagnella GA, Markandu ND, Shore AC, Macgregor GA. 1985 Effects of changes in dietary sodium intake and saline infusion on immunoreactive atrial natriuretic peptide in human plasma. Lancet 2:1208-1210.
10. Needleman P, Greenwald JE. 1986 Atriopeptin: a cardiac hormone intimately involved in fluid, electrolyte, and blood-pressure homeostasis. N Engl J Med. 314:828-834.
11. Nishida Y, Miyata A, Morita H, et al. 1988 Effect of rapid sodium load on circulating atrial natriuretic polypeptide. Am J Physiol. 254:F540-F546.
12. Hodsman G, Jackson B, Debrevi L, Ogawa K, Johnston C. 1987 Atrial natriuretic factor in chronic renal failure: studies in man and in the rat. Clin Exp Pharmacol Physiol. 14:247-251.
13. Mendelsohn F, Hutchison J, Johnston C. 1971 A review of plasma renin measurements and their clinical significance. Aust NZ J Med. 1:86-93.
14. Berns A, Pluss R, Erickson A, Anderson R, McDonald K, Schrier R. 1977 Renin-angiotensin system and cardiovascular homeostasis in adrenal insufficiency. Am J Physiol. 233:F509-F513.
15. Linquette M, Lefebvre J, Fossati P, Fourlinnie J, Cappoen J, Lecieux P. 1975 L'activite renine plasmatique dans la surveillance du traitement de la maladie d'Addison. Ann Endocrinol (Paris). 36:103-104.
16. Brown J, Fraser R, Lever A, et al. 1968 Renin, angiotensin, corticosteroids, and electrolyte balance in Addison's disease. Q J Med. 37:97-118.
17. Reid I, Tu K, Otsuka T, Assaykeen T, Ganong W. 1973 Studies concerning the regulation and importance of plasma angiotensinogen concentration in the dog. Endocrinology. 93:107-114.
18. Carpuccio F, Markandu N, Buckley M, Sugden A, Sagnella G, MacGregor G. 1989 Raised plasma levels of atrial natriuretic peptide in Addison's disease. J Endocrinol Invest. 12:205-207.
19. Conn J, Hinerman D. 1977 Spironolactone-induced inhibition of aldosterone biosynthesis in primary aldosteronism: morphological and functional studies. Metabolism. 26:1293-1307.
20. Goetz K. 1990 Evidence that atriopeptin is not a physiological regulator of sodium excretion. Hypertension. 15:9-19.
21. Singer D, Shore A, Markandu N, Buckley M, Sagnella G, MacGregor G. 1987 Dissociation between plasma atrial natriuretic peptide levels and urinary sodium excretion after intravenous saline infusion in normal man. Clin Sci. 73:285-289.
22. Espiner E, Crozier I, Nicholls M, Cuneo R, Yandle T, Ikram H. 1985 Cardiac secretion of atrial natriuretic peptide. Lancet. 2:398-399.
23. Dal Canton A, Romano G, Conte G, et al. 1990 Role of atrial natruiretic factor in renal adaptation to variation of salt intake. Am J Physiol. 258: F1579-F1583.
24. Lang R, Unger T, Ganten D. 1987 Atrial natriuretic peptide: a new factor in blood pressure control. J Hypertens. 5:255-271.
25. Sagnella G, Markandu N, Shore A, Macgregor G. 1987 Plasma immunoreactive atrial natriuretic peptide and changes in dietary sodium intake in man. Life Sci. 73:285-289.